Šw‰ï”•\2022
Masaru Inatani
Live Imaging for the Enhanced Trabecular Aqueous Outflow After the Topical Administration of ROCK Inhibitor Antiglaucoma Ophthalmic Solution in the Human Eye
The 38th APAO Congress February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Live Imaging for the Enhanced Trabecular Aqueous Outflow After the Topical Administration of ROCK Inhibitor Antiglaucoma Ophthalmic Solution in the Human Eye
The 38th APAO Congress February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Takehiro Matsumura
Long-Term Outcome after Superficial Karatectomy for Partial Limbal Stem Cell Deficiency
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting�@Septermber11,2022 WEB
Long-Term Outcome after Superficial Karatectomy for Partial Limbal Stem Cell Deficiency
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting�@Septermber11,2022 WEB
Shogo Arimura
Chronic Antioxidant Capacity Loss in Anterior Chamber Environment After Iridectomy
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting Septermber11,2022 WEB
Chronic Antioxidant Capacity Loss in Anterior Chamber Environment After Iridectomy
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting Septermber11,2022 WEB
Masaru Inatani
Aqueous column changes in the episcleral veins after the instillation of ripasudil versus latanoprost: A randomized, double-blind, crossover clinical trial
The 38th APAO Congres February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Aqueous column changes in the episcleral veins after the instillation of ripasudil versus latanoprost: A randomized, double-blind, crossover clinical trial
The 38th APAO Congres February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Yutaka Yamada
Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting�@Septermber11,2022 WEB
Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting�@Septermber11,2022 WEB
�‚‘º�@‰À�O
DME(DR)�@
‘æ38‰ñ“ú–{Šá�zŠÂŠw‰ï
—ߘa4”N7ŒŽ16-17“ú�@•xŽR�‘�Û‰ï‹c�ê
�@DME(DR)�@
‘æ38‰ñ“ú–{Šá�zŠÂŠw‰ï
—ߘa4”N7ŒŽ16-17“ú�@•xŽR�‘�Û‰ï‹c�ê
—L‘º�@�®Œå
‘OŠá•”OCT‚ł݂é‹É’á�N�P—Γà�áŽè�p
‘æ33‰ñ“ú–{—Γà�áŠw‰ï
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
‘OŠá•”OCT‚ł݂é‹É’á�N�P—Γà�áŽè�p
‘æ33‰ñ“ú–{—Γà�áŠw‰ï
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
Šâí•�@Œ’‘¾˜Y
iStent‚̃tƒ@ƒNƒgƒ`ƒFƒbƒN
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
iStent‚̃tƒ@ƒNƒgƒ`ƒFƒbƒN
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
îà‘º�@‰À�O
“O’ê“¢˜_�I“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚ŽîŽ¡—Ã�`‰·ŒÌ’m�V�`‚±‚Ì10”N‚Ì�i•à‚ðŒŸ�Ø‚·‚é
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR�[ƒX
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
“O’ê“¢˜_�I“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚ŽîŽ¡—Ã�`‰·ŒÌ’m�V�`‚±‚Ì10”N‚Ì�i•à‚ðŒŸ�Ø‚·‚é
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR�[ƒX
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
îà‘º�@‰À�O
“œ”A•a–Ô–Œ�Ç‚Ì�f’f�`‘�Šú‚Ì”ñ�N�P“I‚È�f’f�`
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
“œ”A•a–Ô–Œ�Ç‚Ì�f’f�`‘�Šú‚Ì”ñ�N�P“I‚È�f’f�`
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
ˆî’J�@‘å
—Γà�á“_ŠáƒAƒhƒqƒAƒ‰ƒ“ƒX‚ÌŽÀ‘Ô�@ƒAƒhƒqƒAƒ‰ƒ“ƒX�`ŠmŽÀ‚È–òŒøŽÀŒ»‚Ì‚½‚ß‚É�`
‘æ42‰ñ“ú–{Šá–ò—�Šw‰ï
—ߘa4”N10ŒŽ29-30“ú�@“Þ—ÇŽs
—Γà�á“_ŠáƒAƒhƒqƒAƒ‰ƒ“ƒX‚ÌŽÀ‘Ô�@ƒAƒhƒqƒAƒ‰ƒ“ƒX�`ŠmŽÀ‚È–òŒøŽÀŒ»‚Ì‚½‚ß‚É�`
‘æ42‰ñ“ú–{Šá–ò—�Šw‰ï
—ߘa4”N10ŒŽ29-30“ú�@“Þ—ÇŽs
ˆî’J�@‘å
гŽÒ‚³‚ñ‚ÉŠñ‚è“Y‚Á‚½—Γà�Ꭱ—Ã�I
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�@�çŽõ�»–ò‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N4ŒŽ14-17“ú�@‘å�ã�‘�Û‰ï‹c�ê
гŽÒ‚³‚ñ‚ÉŠñ‚è“Y‚Á‚½—Γà�Ꭱ—Ã�I
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�@�çŽõ�»–ò‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N4ŒŽ14-17“ú�@‘å�ã�‘�Û‰ï‹c�ê
ˆî’J�@‘å
’´�‚—ŽÐ‰ï‚̗Γà�á�@–ò•¨Ž¡—Â͂±‚¤‚µ‚悤�B
‘æ92‰ñ‹ã�BŠá‰ÈŠw‰ï�@�@�çŽõ�»–ò‹¤�ÃAƒtƒ^ƒk�[ƒ“ƒZƒ~ƒi�[
—ߘa4”N5ŒŽ27-29“ú�@‰«“ꌧ
’´�‚—ŽÐ‰ï‚̗Γà�á�@–ò•¨Ž¡—Â͂±‚¤‚µ‚悤�B
‘æ92‰ñ‹ã�BŠá‰ÈŠw‰ï�@�@�çŽõ�»–ò‹¤�ÃAƒtƒ^ƒk�[ƒ“ƒZƒ~ƒi�[
—ߘa4”N5ŒŽ27-29“ú�@‰«“ꌧ
ˆî’J�@‘å
�uŒoŒ±�v‚Æ�uƒGƒrƒfƒ“ƒX�v‚ÉŠw‚ÔŒ«ŽÒ‚̗Γà�Ꭱ—Ã�@
ŒoŒ±‚ƃGƒrƒfƒ“ƒX‚©‚çŠw‚ԗΓà�á
‘æ33‰ñ“ú–{—Γà�áŠw‰ï�@ƒ”ƒBƒAƒgƒŠƒX�»–ò‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
�uŒoŒ±�v‚Æ�uƒGƒrƒfƒ“ƒX�v‚ÉŠw‚ÔŒ«ŽÒ‚̗Γà�Ꭱ—Ã�@
ŒoŒ±‚ƃGƒrƒfƒ“ƒX‚©‚çŠw‚ԗΓà�á
‘æ33‰ñ“ú–{—Γà�áŠw‰ï�@ƒ”ƒBƒAƒgƒŠƒX�»–ò‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
ˆî’J�@‘å
ƒoƒ‹ƒxƒ‹ƒg‚Í‚±‚¤Žg‚¦�IŒŒŠÇ�V�¶—Γà�á•Ò�@—Γà�á�f’f�EŽ¡—Ã�`Ž„‚Ì�S‚è‚Æ�H•v�`
‘æ33‰ñ“ú–{—Γà�áŠw‰ï�@AMO‹¤�ÃCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
ƒoƒ‹ƒxƒ‹ƒg‚Í‚±‚¤Žg‚¦�IŒŒŠÇ�V�¶—Γà�á•Ò�@—Γà�á�f’f�EŽ¡—Ã�`Ž„‚Ì�S‚è‚Æ�H•v�`
‘æ33‰ñ“ú–{—Γà�áŠw‰ï�@AMO‹¤�ÃCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
ˆî’J�@‘å
Ž„‚Í‚±‚¤‚µ‚Ä‚¢‚Ü‚·�IŽè�p‚̃^ƒCƒ~ƒ“ƒO‚Æ�pŽ®‘I‘ð�@Ž¡—ˉ»‚Ì’n•½‚ðŠJ‚
‘æ33‰ñ“ú–{—Γà�áŠw‰ï�@ŽQ“V�»–ò‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
Ž„‚Í‚±‚¤‚µ‚Ä‚¢‚Ü‚·�IŽè�p‚̃^ƒCƒ~ƒ“ƒO‚Æ�pŽ®‘I‘ð�@Ž¡—ˉ»‚Ì’n•½‚ðŠJ‚
‘æ33‰ñ“ú–{—Γà�áŠw‰ï�@ŽQ“V�»–ò‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
ˆî’J�@‘å
ƒŠƒpƒXƒWƒ‹‚Í–[�…‚Ì—¬‚ê‚ð•Ï‚¦‚ç‚ê‚é‚©�H�`Žå—¬�o˜H‚ÌŽ¡—Ã�í—ª
—Γà�á–ò•¨Ž¡—ÂÌ�V�í—ª
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@‹»˜aДޮ‰ïŽÐ‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ƒŠƒpƒXƒWƒ‹‚Í–[�…‚Ì—¬‚ê‚ð•Ï‚¦‚ç‚ê‚é‚©�H�`Žå—¬�o˜H‚ÌŽ¡—Ã�í—ª
—Γà�á–ò•¨Ž¡—ÂÌ�V�í—ª
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@‹»˜aДޮ‰ïŽÐ‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ˆî’J�@‘å
”F—e�«‚ð�l—¶‚µ‚ÄŽg‚¢‚±‚È‚·
—Γà�á–ò•¨Ž¡—Ã�@”z�‡�Ü‚ðŽg‚¢‚±‚È‚·�I
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@�çŽõ�»–ò‹¤�Â�[ƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
”F—e�«‚ð�l—¶‚µ‚ÄŽg‚¢‚±‚È‚·
—Γà�á–ò•¨Ž¡—Ã�@”z�‡�Ü‚ðŽg‚¢‚±‚È‚·�I
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@�çŽõ�»–ò‹¤�Â�[ƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ˆî’J�@‘å
iStent inject W‚ÌŽg—p�¬�Ñ’²�¸‚𑬕ñ‚µ‚Ü‚·�I
‘�Šú—Γà�á‚ւ̃Aƒvƒ��[ƒ`�`”’“à�áŽè�p•¹—pŠá“àƒhƒŒ�[ƒ“�`
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒOƒ‰ƒEƒRƒXƒWƒƒƒpƒ“‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
iStent inject W‚ÌŽg—p�¬�Ñ’²�¸‚𑬕ñ‚µ‚Ü‚·�I
‘�Šú—Γà�á‚ւ̃Aƒvƒ��[ƒ`�`”’“à�áŽè�p•¹—pŠá“àƒhƒŒ�[ƒ“�`
‘æ76‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒOƒ‰ƒEƒRƒXƒWƒƒƒpƒ“‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N10ŒŽ13-16“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
îà‘º�@‰À�O
�RVEGFŽ¡—Âɔ½‰ž�«‚Ì’á‚¢“œ”A•a‰©”Á•‚Žî‚Ì“ä‚É”—‚é
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï�@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@�[ƒ}‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
�RVEGFŽ¡—Âɔ½‰ž�«‚Ì’á‚¢“œ”A•a‰©”Á•‚Žî‚Ì“ä‚É”—‚é
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï�@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@�[ƒ}‹¤�Ƀ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
îà‘º�@‰À�O
ƒoƒr�[ƒXƒ‚‚ª‚à‚½‚ç‚·DMEŽ¡—Âɂ¨‚¯‚é�V“WŠJ
‘æ61‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�@’†ŠO�»–ò‹¤�ÃCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N12ŒŽ2-4“ú�@‘å�ã�‘�Û‰ï‹c�ê
ƒoƒr�[ƒXƒ‚‚ª‚à‚½‚ç‚·DMEŽ¡—Âɂ¨‚¯‚é�V“WŠJ
‘æ61‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�@’†ŠO�»–ò‹¤�ÃCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N12ŒŽ2-4“ú�@‘å�ã�‘�Û‰ï‹c�ê
îà‘º�@‰À�O
‰æ‘œ‰ð�͂̉ž—p‚É‚æ‚é“�«–Ô–ŒŽ¾Š³‚Ö‚Ì�V‚µ‚¢ƒAƒvƒ��[ƒ`
‘æ61‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�@“ú–{ƒAƒ‹ƒRƒ“‹¤�Â�[ƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N12ŒŽ2-4“ú�@‘å�ã�‘�Û‰ï‹c�ê
‰æ‘œ‰ð�͂̉ž—p‚É‚æ‚é“�«–Ô–ŒŽ¾Š³‚Ö‚Ì�V‚µ‚¢ƒAƒvƒ��[ƒ`
‘æ61‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�@“ú–{ƒAƒ‹ƒRƒ“‹¤�Â�[ƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa4”N12ŒŽ2-4“ú�@‘å�ã�‘�Û‰ï‹c�ê
ˆî’J�@‘å
ƒuƒŠƒ‚ƒjƒWƒ“/ƒ`ƒ‚ƒ��[ƒ‹”z�‡“_Šá�܂̑½Ž{�Ý‹¤“¯–³�ìˆ×‰»ƒNƒ�ƒXƒI�[ƒo�[ŽŽŒ±
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï
—ߘa4”N4ŒŽ14-17“ú�@‘å�ã�‘�Û‰ï‹c�ê
ƒuƒŠƒ‚ƒjƒWƒ“/ƒ`ƒ‚ƒ��[ƒ‹”z�‡“_Šá�܂̑½Ž{�Ý‹¤“¯–³�ìˆ×‰»ƒNƒ�ƒXƒI�[ƒo�[ŽŽŒ±
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï
—ߘa4”N4ŒŽ14-17“ú�@‘å�ã�‘�Û‰ï‹c�ê
�܈ä�@—C‰î
Aqueous column changes after the instillation of ripasudil and latanoprost
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒ�ƒXƒg“_ŠáŒã‚Ì�ã‹–Œ�Ö¬’†‚ÌAqueous column‚̕ω»
‘æ33‰ñ“ú–{—Γà�áŠw‰ï
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
Aqueous column changes after the instillation of ripasudil and latanoprost
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒ�ƒXƒg“_ŠáŒã‚Ì�ã‹–Œ�Ö¬’†‚ÌAqueous column‚̕ω»
‘æ33‰ñ“ú–{—Γà�áŠw‰ï
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
Šâí•�@Œ’‘¾˜Y
Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study
‘æ33‰ñ“ú–{—Γà�áŠw‰ï
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study
‘æ33‰ñ“ú–{—Γà�áŠw‰ï
—ߘa4”N9ŒŽ16-18“ú�@ƒpƒVƒtƒBƒR‰¡•l
�™Œ´�@—F‰À�A�‚‘º�@‰À�O
•Ÿˆä‘åŠw‚É‚¨‚¯‚éƒ��[ƒrƒWƒ‡ƒ“ŠO—ˆ‚ÌŽæ‚è‘g‚Ý
‘æ23‰ñ“ú–{ƒ��[ƒrƒWƒ‡ƒ“Šw‰ïŠw�p‘�‰ï
—ߘa4”N5ŒŽ20-22“ú�@ŽŽ™“‡Žs
•Ÿˆä‘åŠw‚É‚¨‚¯‚éƒ��[ƒrƒWƒ‡ƒ“ŠO—ˆ‚ÌŽæ‚è‘g‚Ý
‘æ23‰ñ“ú–{ƒ��[ƒrƒWƒ‡ƒ“Šw‰ïŠw�p‘�‰ï
—ߘa4”N5ŒŽ20-22“ú�@ŽŽ™“‡Žs
’Ò�@—²�G
L-ƒJƒ‹ƒmƒVƒ“‚ÌŒoŒû“Š—^‚É‚æ‚èCD157ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚̎Љï”Fޝ�áŠQ‚ª‰ü‘P‚·‚é
Oral supplementation with L-carnosine attenuates social recognition deficits in CD157KO mice via oxytocin release
Neuro2022 ‘æ45‰ñ“ú–{�_Œo‰ÈŠw‘å‰ï�^‘æ65‰ñ“ú–{�_Œo‰»Šw‰ï‘å‰ï�^
‘æ32‰ñ“ú–{�_Œo‰ñ˜HŠw‰ï‘å‰ï �‡“¯‘å‰ï
—ߘa4”N6ŒŽ30“ú-7ŒŽ3“ú�@‰«“ꌧ
L-ƒJƒ‹ƒmƒVƒ“‚ÌŒoŒû“Š—^‚É‚æ‚èCD157ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚̎Љï”Fޝ�áŠQ‚ª‰ü‘P‚·‚é
Oral supplementation with L-carnosine attenuates social recognition deficits in CD157KO mice via oxytocin release
Neuro2022 ‘æ45‰ñ“ú–{�_Œo‰ÈŠw‘å‰ï�^‘æ65‰ñ“ú–{�_Œo‰»Šw‰ï‘å‰ï�^
‘æ32‰ñ“ú–{�_Œo‰ñ˜HŠw‰ï‘å‰ï �‡“¯‘å‰ï
—ߘa4”N6ŒŽ30“ú-7ŒŽ3“ú�@‰«“ꌧ
‘哈�@�G�K
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—ÃŒã‚ÌŒŒ“œƒRƒ“ƒgƒ��[ƒ‹‚ɂ‚¢‚Ä
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—ÃŒã‚ÌŒŒ“œƒRƒ“ƒgƒ��[ƒ‹‚ɂ‚¢‚Ä
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
ŽR“c�@—Y‹M
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—Ã
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—Ã
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa4”N10ŒŽ21“ú-22“ú�@�‘—§‹ž“s�‘�Û‰ïŠÙ
—L‘º�@�®Œå
�üˆÛ’Œ‘Ñ�Ø�œ�p‚Æ”’“à�á‚ÌŠÖŒW
–k—¤—Γà�áƒZƒ~ƒi�[ from•ŸƒCƒC�I
—ߘa4”N4ŒŽ21“ú�@•ŸˆäŽs �iWEBŠJ�Ã)
�üˆÛ’Œ‘Ñ�Ø�œ�p‚Æ”’“à�á‚ÌŠÖŒW
–k—¤—Γà�áƒZƒ~ƒi�[ from•ŸƒCƒC�I
—ߘa4”N4ŒŽ21“ú�@•ŸˆäŽs �iWEBŠJ�Ã)
ˆî’J�@‘å
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�Ꭱ—Ã�@ŒŒŠÇ�V�¶—Γà�á•Ò
‘æ29‰ñHOT
—ߘa4”N4ŒŽ22“ú�@“Œ‹ž“s
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�Ꭱ—Ã�@ŒŒŠÇ�V�¶—Γà�á•Ò
‘æ29‰ñHOT
—ߘa4”N4ŒŽ22“ú�@“Œ‹ž“s
ˆî’J�@‘å
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�áŽè�p�@�`MIGS•Ò�`
‘æ13‰ñ�¹ƒ}ƒŠƒAƒ“ƒiŠá‰È—Õ�°ƒtƒH�[ƒ‰ƒ€
—ߘa4”N5ŒŽ14“ú�@�_“Þ�쌧�ì�èŽs
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�áŽè�p�@�`MIGS•Ò�`
‘æ13‰ñ�¹ƒ}ƒŠƒAƒ“ƒiŠá‰È—Õ�°ƒtƒH�[ƒ‰ƒ€
—ߘa4”N5ŒŽ14“ú�@�_“Þ�쌧�ì�èŽs
ˆî’J�@‘å
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�á–ò•¨Ž¡—Ã�`ƒKƒCƒhƒ‰ƒCƒ“•Ò�`
“ì‘å�ãƒAƒCƒtƒH�[ƒ‰ƒ€
—ߘa4”N6ŒŽ2“ú�@‘å�ã•{�äŽs
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�á–ò•¨Ž¡—Ã�`ƒKƒCƒhƒ‰ƒCƒ“•Ò�`
“ì‘å�ãƒAƒCƒtƒH�[ƒ‰ƒ€
—ߘa4”N6ŒŽ2“ú�@‘å�ã•{�äŽs
îà‘º�@‰À�O
“œ”A•a‰©”Á•‚Žî‚Ì‘S�gŠÇ—�
Novartis DME Web Seminar
—ߘa4”N6ŒŽ2“ú�@WEB”z�M
“œ”A•a‰©”Á•‚Žî‚Ì‘S�gŠÇ—�
Novartis DME Web Seminar
—ߘa4”N6ŒŽ2“ú�@WEB”z�M
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�zƒAƒCƒx�[ƒ^“Á’è—Õ�°Œ¤‹†
SENJU Web Seminar
—ߘa4”N6ŒŽ23“ú�@•ŸˆäŒ§‚©‚ç‘S�‘Web”z�M
�y‚ä‚Á‚‚è‰ð�à�zƒAƒCƒx�[ƒ^“Á’è—Õ�°Œ¤‹†
SENJU Web Seminar
—ߘa4”N6ŒŽ23“ú�@•ŸˆäŒ§‚©‚ç‘S�‘Web”z�M
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2022
‘æ153‰ñ�L“‡Œ§Šá‰Èˆã‰ï�u�K‰ï
—ߘa4”N7ŒŽ3“ú�@�L“‡Žs
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2022
‘æ153‰ñ�L“‡Œ§Šá‰Èˆã‰ï�u�K‰ï
—ߘa4”N7ŒŽ3“ú�@�L“‡Žs
îà‘º�@‰À�O
ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚Žî‚ɑ΂·‚鎡—Ã
Shimbashi Ophthalmic Seminar
—ߘa4”N7ŒŽ4“ú�@Web”z�M
ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚Žî‚ɑ΂·‚鎡—Ã
Shimbashi Ophthalmic Seminar
—ߘa4”N7ŒŽ4“ú�@Web”z�M
ˆî’J�@‘å
ƒOƒ‰ƒiƒeƒbƒN‚ª–[�…‚Ì—¬‚ê‚ð•Ï‚¦‚é�I�`Žå—¬�o˜H‚ÌŽ¡—Ã�í—ª�`
ƒOƒ‰ƒiƒeƒbƒN Web ƒJƒ“ƒtƒ@ƒŒƒ“ƒX
—ߘa4”N9ŒŽ29“ú�@“Œ‹ž“s‚©‚ç‘S�‘Web”z�M
ƒOƒ‰ƒiƒeƒbƒN‚ª–[�…‚Ì—¬‚ê‚ð•Ï‚¦‚é�I�`Žå—¬�o˜H‚ÌŽ¡—Ã�í—ª�`
ƒOƒ‰ƒiƒeƒbƒN Web ƒJƒ“ƒtƒ@ƒŒƒ“ƒX
—ߘa4”N9ŒŽ29“ú�@“Œ‹ž“s‚©‚ç‘S�‘Web”z�M
îà‘º�@‰À�O
Ž¡—Ã’ï�R�«‚Ì“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGF—Ö@‚ð�l‚¦‚é
‘æ6‰ñƒAƒCƒŠ�[ƒA‰©”Á޾гƒZƒ~ƒi�[in�²‰ê
—ߘa4”N10ŒŽ1“ú�@Web”z�M
Ž¡—Ã’ï�R�«‚Ì“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGF—Ö@‚ð�l‚¦‚é
‘æ6‰ñƒAƒCƒŠ�[ƒA‰©”Á޾гƒZƒ~ƒi�[in�²‰ê
—ߘa4”N10ŒŽ1“ú�@Web”z�M
îà‘º�@‰À�O
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—Âɂ¨‚¯‚é”Y‚݂ƑŊJ�ô
‘æ2‰ñ’z’nƒIƒtƒTƒ‹ƒ~ƒbƒNƒZƒ~ƒi�[
—ߘa4”N10ŒŽ6“ú�@Web”z�M
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—Âɂ¨‚¯‚é”Y‚݂ƑŊJ�ô
‘æ2‰ñ’z’nƒIƒtƒTƒ‹ƒ~ƒbƒNƒZƒ~ƒi�[
—ߘa4”N10ŒŽ6“ú�@Web”z�M
ŽR“c�@—Y‹M
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—Âł̖ԖŒŒú‰ü‘P—¦‚Ì•”ˆÊ•Ê‘Šˆá
‘æ7‰ñŽáŽèDRŒ¤‹†‰ï
—ߘa4”N10ŒŽ21“ú�@‹ž“sŽs
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGFŽ¡—Âł̖ԖŒŒú‰ü‘P—¦‚Ì•”ˆÊ•Ê‘Šˆá
‘æ7‰ñŽáŽèDRŒ¤‹†‰ï
—ߘa4”N10ŒŽ21“ú�@‹ž“sŽs
Œã‘ò�@�½
MPS–@‚ð‰ž—p‚µ‚½3D�ÉŽq‘Ì�o‚É‚¨‚¯‚éretro-oil fluid‚Ì‹““®‰ð�Í
Prometech Simulation Conference 2022
—ߘa4”N11ŒŽ9“ú�@Web”z�M
MPS–@‚ð‰ž—p‚µ‚½3D�ÉŽq‘Ì�o‚É‚¨‚¯‚éretro-oil fluid‚Ì‹““®‰ð�Í
Prometech Simulation Conference 2022
—ߘa4”N11ŒŽ9“ú�@Web”z�M
ˆî’J�@‘å
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�á–ò•¨Ž¡—Ã�`ƒKƒCƒhƒ‰ƒCƒ“•Ò�`
‘æ20‰ñ�‚’mŠá‰Š�ÇŒ¤‹†‰ï�@
—ߘa4”N11ŒŽ12“ú�@�‚’mŽs
ƒGƒNƒXƒgƒŠ�[ƒ€�I—Γà�á–ò•¨Ž¡—Ã�`ƒKƒCƒhƒ‰ƒCƒ“•Ò�`
‘æ20‰ñ�‚’mŠá‰Š�ÇŒ¤‹†‰ï�@
—ߘa4”N11ŒŽ12“ú�@�‚’mŽs
�¼‘º�@Œ’‘å
Š´�õ�«Šp–Œ‰Š‚Ì‘OŠá•”‰æ‘œŒŸ�¸
‘æ46‰ñCOST
—ߘa4”N11ŒŽ15“ú�@Web”z�M
Š´�õ�«Šp–Œ‰Š‚Ì‘OŠá•”‰æ‘œŒŸ�¸
‘æ46‰ñCOST
—ߘa4”N11ŒŽ15“ú�@Web”z�M
ˆî’J�@‘å
�u‚ä‚Á‚‚è‰ð�à�v—Γà�á“_Šá–ò2022
‘æ11‰ñ“ÈŠáˆãàÕ‹¦Šá‰È•a�f˜AŒg‚̉ï�@
—ߘa4”N11ŒŽ17“ú�@“È–ØŒ§‰F“s‹{Žs
�u‚ä‚Á‚‚è‰ð�à�v—Γà�á“_Šá–ò2022
‘æ11‰ñ“ÈŠáˆãàÕ‹¦Šá‰È•a�f˜AŒg‚̉ï�@
—ߘa4”N11ŒŽ17“ú�@“È–ØŒ§‰F“s‹{Žs
ˆî’J�@‘å
ƒ`ƒ…�[ƒuƒVƒƒƒ“ƒgŽè�p‚ɂ‚¢‚Ä
“Œ‹ž‘åŠw�E•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú�@Web”z�M
ƒ`ƒ…�[ƒuƒVƒƒƒ“ƒgŽè�p‚ɂ‚¢‚Ä
“Œ‹ž‘åŠw�E•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú�@Web”z�M
ˆî’J�@‘å
�Å‘¬‚ł킩‚éNVGŽÀ—Õ�°
KANSAI RVO/NVG WEB SEMINAR 2022
—ߘa4”N12ŒŽ15“ú�@‹ß‹E’n‹æ‚ÖWeb”z�M
�Å‘¬‚ł킩‚éNVGŽÀ—Õ�°
KANSAI RVO/NVG WEB SEMINAR 2022
—ߘa4”N12ŒŽ15“ú�@‹ß‹E’n‹æ‚ÖWeb”z�M
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2023
‘æ19‰ñ�ÓìŠá‰È‹äŠy•”
—ߘa5”N1ŒŽ12“ú�@�_“Þ�ìŒ§Š™‘qŽs
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2023
‘æ19‰ñ�ÓìŠá‰È‹äŠy•”
—ߘa5”N1ŒŽ12“ú�@�_“Þ�ìŒ§Š™‘qŽs
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�áŽè�pŽ¡—Ã2023
•Ÿ‰ªŒ§Šá‰ÈŠwWebƒZƒ~ƒi�[
—ߘa5”N1ŒŽ19“ú�@•Ÿ‰ªŒ§‚ÖWeb”z�M
�y‚ä‚Á‚‚è‰ð�à�z—Γà�áŽè�pŽ¡—Ã2023
•Ÿ‰ªŒ§Šá‰ÈŠwWebƒZƒ~ƒi�[
—ߘa5”N1ŒŽ19“ú�@•Ÿ‰ªŒ§‚ÖWeb”z�M
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á‚Ì�ϋɎ¡—Ã
SENJU Web Seminar
—ߘa5”N1ŒŽ20“ú�@•ŸˆäŒ§‚©‚ç‘S�‘‚ÖWeb”z�M
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á‚Ì�ϋɎ¡—Ã
SENJU Web Seminar
—ߘa5”N1ŒŽ20“ú�@•ŸˆäŒ§‚©‚ç‘S�‘‚ÖWeb”z�M
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]’´�‚—ŽÐ‰ï‚̗Γà�áŽè�p
‘æ363‰ñŠâŽèŠá‰È�W’k‰ï
—ߘa5”N1ŒŽ21“ú�@ŠâŽèŒ§�·‰ªŽs
[‚ä‚Á‚‚è‰ð�à]’´�‚—ŽÐ‰ï‚̗Γà�áŽè�p
‘æ363‰ñŠâŽèŠá‰È�W’k‰ï
—ߘa5”N1ŒŽ21“ú�@ŠâŽèŒ§�·‰ªŽs
îà‘º�@‰À�O
DME‚ɑ΂·‚é�RVEGF–ò‚Ì•p‰ñ“Š—^‚ɂ‚¢‚Ä�Ä�l‚·‚é
‘æ8‰ñŽŽ™“‡Šá޾гƒtƒH�[ƒ‰ƒ€
—ߘa5”N1ŒŽ21“ú�@ŽŽ™“‡Œ§
DME‚ɑ΂·‚é�RVEGF–ò‚Ì•p‰ñ“Š—^‚ɂ‚¢‚Ä�Ä�l‚·‚é
‘æ8‰ñŽŽ™“‡Šá޾гƒtƒH�[ƒ‰ƒ€
—ߘa5”N1ŒŽ21“ú�@ŽŽ™“‡Œ§
Šâí•�@Œ’‘¾˜Y
Šá‰ÈƒXƒ^ƒbƒt•KŒ©�I—Γà�áŽè�p‚ð�®—�‚·‚é
Šá‰ÈƒXƒ^ƒbƒtƒZƒ~ƒi�[in•Ÿˆä�@
—ߘa5”N1ŒŽ25“ú Web”z�M
Šá‰ÈƒXƒ^ƒbƒt•KŒ©�I—Γà�áŽè�p‚ð�®—�‚·‚é
Šá‰ÈƒXƒ^ƒbƒtƒZƒ~ƒi�[in•Ÿˆä�@
—ߘa5”N1ŒŽ25“ú Web”z�M
îà‘º�@‰À�O
“œ”A•a‰©”Á•‚Žî�@‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg
“à‰È‚ÆŠá‰È‚̈ã—ØAŒg‚ð�l‚¦‚é�`�V‚µ‚¢�t�«•nŒŒŽ¡—Öò‚𓥂܂¦‚Ä�`
—ߘa5”N2ŒŽ3“ú�@•Ÿˆä�¤�H‰ï‹c�Š
“œ”A•a‰©”Á•‚Žî�@‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg
“à‰È‚ÆŠá‰È‚̈ã—ØAŒg‚ð�l‚¦‚é�`�V‚µ‚¢�t�«•nŒŒŽ¡—Öò‚𓥂܂¦‚Ä�`
—ߘa5”N2ŒŽ3“ú�@•Ÿˆä�¤�H‰ï‹c�Š
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2023
‘æ13‰ñ�ɪŒ§Šá‰ÈƒtƒH�[ƒ‰ƒ€
—ߘa5”N2ŒŽ18“ú�@�ɪŽs
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2023
‘æ13‰ñ�ɪŒ§Šá‰ÈƒtƒH�[ƒ‰ƒ€
—ߘa5”N2ŒŽ18“ú�@�ɪŽs
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á”z�‡“_Šá–ò2023
Kowa WebƒJƒ“ƒtƒ@ƒŒƒ“ƒX ’}Œã—Γà�á�u‰‰‰ï
—ߘa5”N2ŒŽ28“ú�@•Ÿ‰ªŒ§‚ÖWeb”z�M
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á”z�‡“_Šá–ò2023
Kowa WebƒJƒ“ƒtƒ@ƒŒƒ“ƒX ’}Œã—Γà�á�u‰‰‰ï
—ߘa5”N2ŒŽ28“ú�@•Ÿ‰ªŒ§‚ÖWeb”z�M
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�áŽè�pŽ¡—Ã2023
�L“‡Œ§Šá‰ÈŠwWebƒZƒ~ƒi�[�@
—ߘa5”N3ŒŽ16“ú�@�L“‡Žs‚ÖWEB”z�M
�y‚ä‚Á‚‚è‰ð�à�z—Γà�áŽè�pŽ¡—Ã2023
�L“‡Œ§Šá‰ÈŠwWebƒZƒ~ƒi�[�@
—ߘa5”N3ŒŽ16“ú�@�L“‡Žs‚ÖWEB”z�M
Žs‹´ —SŽu�AŒã‘ò �½�A�‚‘º ‰À�O�A�Â–Ø •üŒb�AŠâ�è Œ’‘¾˜Y�A
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ348‰ñ‹à‘òŠá‰È�W’k‰ï�@—ߘa4”N4ŒŽ24“ú�@‹à‘òŽs
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ348‰ñ‹à‘òŠá‰È�W’k‰ï�@—ߘa4”N4ŒŽ24“ú�@‹à‘òŽs
Œã‘ò�@�½
Application of moving particle semi-implicit(MPS)method on retro-oil fluid using three-dimentional vitreous cavity models from magnetic resonance imaging
‘æ6‰ñ–k—¤4‘åŠwŠá‰È�‡“¯Œ¤‹†‰ï�@—ߘa4”N6ŒŽ3“ú�@‹à‘òŽs�@WEB”z�M
Application of moving particle semi-implicit(MPS)method on retro-oil fluid using three-dimentional vitreous cavity models from magnetic resonance imaging
‘æ6‰ñ–k—¤4‘åŠwŠá‰È�‡“¯Œ¤‹†‰ï�@—ߘa4”N6ŒŽ3“ú�@‹à‘òŽs�@WEB”z�M
Žs‹´ —SŽu�AŒã‘ò �½�A�‚‘º ‰À�O�A�Â–Ø •üŒb�AŠâ핌’‘¾˜Y�Aˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ85‰ñ•xŽRŠá‰È�W’k‰ï�@—ߘa4”N6ŒŽ12“ú�@•xŽRŽs‚æ‚èWEB”z�M
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ85‰ñ•xŽRŠá‰È�W’k‰ï�@—ߘa4”N6ŒŽ12“ú�@•xŽRŽs‚æ‚èWEB”z�M
�܈ä�@—C‰î
ƒvƒ�ƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŠÖ˜A–ò‚Ƃ̕¹—p—Ö@‚Æ‚µ‚Ä‚Ì�AƒuƒŠƒ‚ƒjƒWƒ“0.1�“�^ƒ`ƒ‚ƒ��[ƒ‹0.5�“‚ƃhƒ‹ƒ]ƒ‰ƒ~ƒh1�“�^ƒ`ƒ‚ƒ��[ƒ‹0.5�“�‡�܂̗LŒø�«‚Æ”E—e�«‚Ì”äŠrŒŸ“¢�FAibeta Crossover Study
‘æ7‰ñAGTS‚̉ï�@—ߘa4”N7ŒŽ8“ú�@WEB”z�M
ƒvƒ�ƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŠÖ˜A–ò‚Ƃ̕¹—p—Ö@‚Æ‚µ‚Ä‚Ì�AƒuƒŠƒ‚ƒjƒWƒ“0.1�“�^ƒ`ƒ‚ƒ��[ƒ‹0.5�“‚ƃhƒ‹ƒ]ƒ‰ƒ~ƒh1�“�^ƒ`ƒ‚ƒ��[ƒ‹0.5�“�‡�܂̗LŒø�«‚Æ”E—e�«‚Ì”äŠrŒŸ“¢�FAibeta Crossover Study
‘æ7‰ñAGTS‚̉ï�@—ߘa4”N7ŒŽ8“ú�@WEB”z�M
Žs‹´ —SŽu�AŒã‘ò �½�A�‚‘º ‰À�O�A�Â–Ø •üŒb�AŠâí• Œ’‘¾˜Y�A
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ75‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï�@—ߘa4”N9ŒŽ3“ú�@•ŸˆäŽs
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ75‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï�@—ߘa4”N9ŒŽ3“ú�@•ŸˆäŽs
“c’†�@Œ’Œå�A—é–Ø –œ—�Œb�A�Üˆä —C‰î�A—é–Ø—z•½�A�¬�X—Á•½�A
—L‘º �®Œå�AŠâí• Œ’‘¾˜Y�Aîà‘º ‰À�O�Aˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒ�ƒXƒg“_ŠáŒã‚Ì�ã‹–Œ�Ö¬‚É‚¨‚¯‚é–[�…ƒJƒ‰ƒ€‚̕ω»
‘æ42‰ñ‹à‘òˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï�@—ߘa4”N11ŒŽ6“ú�@‹à‘òŽs
—L‘º �®Œå�AŠâí• Œ’‘¾˜Y�Aîà‘º ‰À�O�Aˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒ�ƒXƒg“_ŠáŒã‚Ì�ã‹–Œ�Ö¬‚É‚¨‚¯‚é–[�…ƒJƒ‰ƒ€‚̕ω»
‘æ42‰ñ‹à‘òˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï�@—ߘa4”N11ŒŽ6“ú�@‹à‘òŽs
“c’†�@Œ’Œå�A—é–Ø –œ—�Œb�A�Üˆä —C‰î�A—é–Ø—z•½�A�¬�X—Á•½�A
—L‘º �®Œå�AŠâí• Œ’‘¾˜Y�Aîà‘º ‰À�O�Aˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒ�ƒXƒg“_ŠáŒã‚Ì�ã‹–Œ�Ö¬‚É‚¨‚¯‚é–[�…ƒJƒ‰ƒ€‚̕ω»
‘æ86‰ñ•xŽRŠá‰È�W’k‰ï�@—ߘa4”N11ŒŽ23“ú�@•xŽRŽs�iƒnƒCƒuƒŠƒbƒhŠJ�Ã�j
—L‘º �®Œå�AŠâí• Œ’‘¾˜Y�Aîà‘º ‰À�O�Aˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒ�ƒXƒg“_ŠáŒã‚Ì�ã‹–Œ�Ö¬‚É‚¨‚¯‚é–[�…ƒJƒ‰ƒ€‚̕ω»
‘æ86‰ñ•xŽRŠá‰È�W’k‰ï�@—ߘa4”N11ŒŽ23“ú�@•xŽRŽs�iƒnƒCƒuƒŠƒbƒhŠJ�Ã�j
�܈ä�@—C‰î
ƒAƒCƒx�[ƒ^ƒNƒ�ƒXƒI�[ƒo�[ŽŽŒ±
“Œ‹ž‘åŠw�E•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú�@Web”z�M
ƒAƒCƒx�[ƒ^ƒNƒ�ƒXƒI�[ƒo�[ŽŽŒ±
“Œ‹ž‘åŠw�E•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú�@Web”z�M
ˆ¢•”�@—DŽ÷�A�܈ä�@—S‰î�AŽR“c�@—Y‹M�A�·‰ª�@�³˜a�A
Šâí•�@Œ’‘¾˜Y�A—L‘º�@�®Œå�Aˆî’J�@‘å
0.1�“ƒuƒŠƒ‚ƒjƒWƒ“Žð�ÎŽ_‰–�^0.5�“ƒ`ƒ‚ƒ��[ƒ‹”z�‡“_Šá�Ü‚Ì�l‘g�D‚É‚¨‚¯‚éŠá‘g�D•ª•z
‘æ349‰ñ‹à‘òŠá‰È�W’k‰ï�@—ߘa4”N12ŒŽ18“ú�@‹à‘òŽs
Šâí•�@Œ’‘¾˜Y�A—L‘º�@�®Œå�Aˆî’J�@‘å
0.1�“ƒuƒŠƒ‚ƒjƒWƒ“Žð�ÎŽ_‰–�^0.5�“ƒ`ƒ‚ƒ��[ƒ‹”z�‡“_Šá�Ü‚Ì�l‘g�D‚É‚¨‚¯‚éŠá‘g�D•ª•z
‘æ349‰ñ‹à‘òŠá‰È�W’k‰ï�@—ߘa4”N12ŒŽ18“ú�@‹à‘òŽs
Žs‹´�@—SŽu
Œ£Šá—v�¿�Aˆã‹Ç‚łǂ¤‘Ήž‚µ‚Ä‚é�H
‘æ76‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï�@—ߘa5”N1ŒŽ14“ú�@•Ÿˆä�¤�H‰ï‹c�Š
Œ£Šá—v�¿�Aˆã‹Ç‚łǂ¤‘Ήž‚µ‚Ä‚é�H
‘æ76‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï�@—ߘa5”N1ŒŽ14“ú�@•Ÿˆä�¤�H‰ï‹c�Š
‰ß‹Ž‚Ì‹Æ�Ñ
Šw‰ï”•\�@2025
Šw‰ï”•\�@2024
Šw‰ï”•\�@2023
Šw‰ï”•\�@2022
Šw‰ï”•\�@2021
Šw‰ï”•\�@2020
Šw‰ï”•\�@2019
Šw‰ï”•\�@2018
Šw‰ï”•\�@2017
Šw‰ï”•\�@2016
Šw‰ï”•\�@2015
Šw‰ï”•\�@2014
Šw‰ï”•\�@2013
Šw‰ï”•\�@2012





![“ü‹Ç‚ðŠó–]‚·‚éŠF—l‚Ö](../../images/global_05.png)

